eli lilly tirzepatide news today Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth Zepbound Is Now Available in

In March, Eli Lilly revealed that it has identified bacteria and elevated impurity levels in products falsely claiming to be compounded versions of tirzepatide, the active ingredient in its widely-used diabetes medication Mounjaro and the weight loss treatment Zepbound

Two novel upstream regulators of LDHA, STAT and LINC00671, have been identified to have close association with glycolysis in PTC

Skin & Body Treatments We offer a Variety of Preventative & Renewal Treatments Sandton Aesthetics Institute is located in Parkmore and led by the internationally acclaimed Dr Alastair Clark

Your doctor will prescribe the most appropriate option based on your health profile

Patient testimonials and success stories showcase the life-changing effects expert clinics have on health journeys